循環性腫瘍細胞(CTC)の世界市場

◆英語タイトル:Circulating Tumor Cells - Global Market Outlook (2015-2022)
◆商品コード:SMRC65046
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:132
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、循環性腫瘍細胞(CTC)の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・循環性腫瘍細胞(CTC)の世界市場:技術別分析/市場規模
・循環性腫瘍細胞(CTC)の世界市場:用途別分析/市場規模
・循環性腫瘍細胞(CTC)の世界市場:地域別分析/市場規模
・循環性腫瘍細胞(CTC)のアメリカ市場規模予測
・循環性腫瘍細胞(CTC)のヨーロッパ市場規模予測
・循環性腫瘍細胞(CTC)のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Circulating Tumor Cells Market is accounted for $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.
Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds.

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Technologies Covered:
• Tumor Cell Enrichment
o Filtration
o Centrifugation
o Immunological and Immunomagnetic
• Tumor Cell Detection
o Molecular
o Optical

Applications Covered:
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Circulating Tumor Cells Market, By Technology
5.1 Introduction
5.2 Tumor Cell Enrichment
5.2.1 Filtration
5.2.2 Centrifugation
5.2.3 Immunological and Immunomagnetic
5.3 Tumor Cell Detection
5.3.1 Molecular
5.3.2 Optical

6 Global Circulating Tumor Cells Market, By Applications
6.1 Introduction
6.2 Breast Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Other Applications

7 Global Circulating Tumor Cells Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Adnagen AG
9.2 Advanced Cell Diagnostics
9.3 Apocell
9.4 Aviva Biosciences
9.5 Biocep Ltd.
9.6 Biocept Inc.
9.7 Biofluidica
9.8 Canopus Biosciences
9.9 CellTraffix Inc.
9.10 Clearbridge BioMedics
9.11 Creatv Microtech Inc.
9.12 Cynvenio Biosystems Inc.
9.13 Epic Biosciences
9.14 Fluxion Biosciences.
9.15 Greiner Bio-One GmbH
9.16 Ikonisys Inc.
9.17 IV Diagnostics Inc.
9.18 Janssen Diagnostics
9.19 Miltenyi Biotech
9.20 Nanostring Technologies Inc.

List of Tables
Table 1 Global Circulating Tumor Cells Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 3 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 4 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 6 Global Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 7 Global Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 8 Global Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 9 Global Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 10 Global Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 11 North America Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 12 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 13 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 14 North America Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 15 North America Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 16 North America Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 18 North America Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 19 North America Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 20 Europe Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 21 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 22 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 23 Europe Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 24 Europe Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 25 Europe Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 26 Europe Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 27 Europe Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 28 Aisa Pacific Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 29 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 30 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 31 Aisa Pacific Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 32 Aisa Pacific Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 34 Aisa Pacific Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 35 Aisa Pacific Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 36 Aisa Pacific Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 37 Rest of the World Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 38 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 39 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 40 Rest of the World Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 41 Rest of the World Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 42 Rest of the World Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 43 Rest of the World Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 44 Rest of the World Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)



【レポートのキーワード】

循環性腫瘍細胞(CTC)、腫瘍細胞検出、濾過、乳癌、結腸直腸癌、前立腺癌

★調査レポート[循環性腫瘍細胞(CTC)の世界市場]販売に関する免責事項
★調査レポート[循環性腫瘍細胞(CTC)の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆